An experimental cancer drug proved a 100 percent success rate in a small study trial on patients with rectal cancer conducted by doctors at New York's Memorial Sloan Kettering Cancer Center. A group of 18 anal cancer patients showed no signs of a tumor after taking antibody drugs for six months, according to surprising findings from an ongoing medical study in the United States. However apart from their tumors completely disappearing, none of the participants experienced any severe side effects, according to a recent study published in the New England Journal of Medicine. The patient underwent a series of tests including a physical examination, endoscopy, cinema, PET scan, and MRI scan, but none of the results showed a tumor. "All 18 patients had a complete clinical response with no signs of magnetic resonance imaging," the researchers write. "To measure the length of reaction, a longer follow-up is required," they stressed. The researchers seek to see if Do
Shujaat Hussain Abbasi, a former student of the Mass Communication Department at Sindh University, has developed this news blog.